周围神经系统中的隐基因受体:对肥胖治疗和周围神经病变的影响
Erica de Sousa1, Lauren Sparks2, Kristy Townsend1
1Department of Neurological Surgery, College of Medicine, The Ohio State University, Columbus, OH.
新的因克雷受体药物提供代谢益处,并可能治疗神经退行性疾病. 它们在周围神经系统 (PNS) 中的作用是代谢健康和治疗神经损伤的关键.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
背景情况:
- 胰岛素受体激活剂彻底改变了肥胖和糖尿病的治疗方法.
- 这些药物显示出超出代谢效应的神经退行性疾病的前景.
- 周围神经系统 (PNS) 中的因克列受体表达未得到充分研究,但显著.
研究的目的:
- 审查当前关于INCRETIN受体和PNS中药物作用的知识.
- 探索PNS在控制因克列释放中的作用.
- 讨论对代谢疾病和外围神经病变的影响.
主要方法:
- 审查关于PNS中的素受体的现有文献.
- 对因克雷丁药物对外围神经功能影响的分析.
- 检查PNS控制机制对cretin分泌的检查.
主要成果:
- 胰岛素受体存在于各种PNS神经元和细胞中,包括脂肪组织中的细胞.
- 神经系统通过肠道和交感神经元调节肠道内素释放 (GLP-1,GIP).
- 印克雷丁药物显示出治疗外围神经疾病的潜力.
结论:
- 皮质神经系统在新陈代谢调节和隐素通路中起着至关重要的作用.
- 胰岛素药物代表了对外围神经病变的有希望的治疗途径.
- 对于代谢疾病相关的神经退化,需要进一步研究因克雷丁药物的药理动力学.
更多相关视频
08:32Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
07:29Real-time Analysis of Gut-brain Neural Communication: Cortex wide Calcium Dynamics in Response to Intestinal Glucose Stimulation
Published on: December 29, 2023
相关概念视频
Regulation of Food Intake
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Insulin: The Receptor and Signaling Pathways
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
